journal article·2026-04Open access

Ganoderma lucidum polysaccharide-decorated extracellular vesicle enables synergistical antitumor immunotherapy

Zhaorong Ouyang, Siyu Li, Ao Zhang, Shu Ye, Wanqiu Ye, Guolei Wen, Tao Wei, Biao Cai, Houli Liu

Abstract

Ganoderma lucidum polysaccharide (GLP) holds considerable promise for tumor therapy, but its clinical application is limited by its poor tumor-targeting capability. Herein, we report the development of an immunoregulatory nano-bioconjugate formed by conjugating GLPs with low-pH culture medium reprogrammed CT26 tumor cell-derived extracellular vesicle (LTEV). Specifically, 4-carboxybenzeneboronic acid (CPBA), used as an intermediate coupling agent, is conjugated with the amino group of LTEV via its carboxyl group to obtain CPBA-LTEV. GLP is then covalently linked via boric ester linkages between its hydroxyl groups and the boronic acid groups of CPBA. After systemic administration, GLP@LTEV accumulates in homologous tumor tissues derived from the LTEV parent cells, remodeling the immunosuppressive tumor microenvironment (TME) by repolarizing M2-like macrophages towards the M1 phenotype, promoting dendritic cell (DC) maturation, activating cytotoxic T lymphocytes (CTLs), and inhibiting immunosuppressive regulatory T cells (Tregs). The synergism of tumor-targeting delivery and potent immunomodulatory effects in this combined manner therefore significantly inhibits subcutaneous tumor growth and lung metastasis with minimal side effects, providing a novel combination of polysaccharide and nanovesicle for robust tumor immunotherapy. GLP@LTEV effectively accumulates in tumor tissues and significantly reverse the immunosuppressive TME via repolarizing M2 macrophages towards M1 phenotype, promoting DC maturation, activating CTLs, and inhibiting Tregs for robust tumor immunotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Fungal Biology and Applications · Nanoplatforms for cancer theranostics · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN10.1136/gutjnl-2022-327736 ↗
2. Changing epidemiology of colorectal cancer-birth cohort effects and emerging risk factors10.1038/s41575-023-00841-9 ↗
3. The tumor microenvironment10.1016/j.cub.2020.06.081 ↗
4. Tumor Microenvironment Shapes Colorectal cancer progression, metastasis, and treatment responses
5. Advances in targeting tumor microenvironment for immunotherapy
6. Regulation and function of tumor-associated macrophages (TAMs) in colorectal cancer (CRC): the role of the SRIF system in macrophage regulation10.3390/ijms26115336 ↗
7. Regulatory T-cells: the face-off of the immune balance10.31083/j.fbl2911377 ↗
8. Cold tumors: a therapeutic challenge for immunotherapy10.3389/fimmu.2019.00168 ↗
9. Cold and hot tumors: from molecular mechanisms to targeted therapy10.1038/s41392-024-01979-x ↗
10. Immunologic tumor microenvironment modulators for turning cold tumors hot10.1002/cac2.12539 ↗
11. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy10.1038/s41571-019-0175-7 ↗
12. Nanoengineered immune niches for reprogramming the immunosuppressive tumor microenvironment and enhancing cancer immunotherapy10.1002/adma.201803322 ↗
13. A review of Ganoderma lucidum polysaccharides: health benefit, structure–activity relationship, modification, and nanoparticle encapsulation10.1016/j.ijbiomac.2023.125199 ↗
14. Effects of the antlered form of Ganoderma lucidum on tumor growth and metastasis in cyclophosphamide-treated mice10.1271/bbb.70607 ↗
15. Ganoderma atrum polysaccharide modulates the M1/M2 polarization of macrophages linked to the Notch signaling pathway10.1039/D1FO04309A ↗
16. Research progress on the anticancer activities and mechanisms of polysaccharides from Ganoderma
17. Antioxidant and immunoregulatory activity of Ganoderma lucidum polysaccharide (GLP)10.1016/j.carbpol.2013.02.081 ↗
18. Ganoderma lucidum spore polysaccharide inhibits the growth of hepatocellular carcinoma cells by altering macrophage polarity and induction of apoptosis10.1155/2021/6696606 ↗
19. Ganoderma lucidum polysaccharide supplementation significantly activates T-cell-mediated antitumor immunity and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer10.1021/acs.jafc.3c08385 ↗
20. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides10.1016/S0165-2478(02)00087-1 ↗
21. Comparison of immunoregulatory effects of polysaccharides from three natural herbs and cellular uptake in dendritic cells10.1016/j.ijbiomac.2016.09.064 ↗
22. Analysis of maturation of murine dendritic cells (DCs) induced by purified Ganoderma lucidum polysaccharides (GLPs)10.1016/j.ijbiomac.2011.06.029 ↗
23. Effective radiotherapy in tumor assisted by Ganoderma lucidum polysaccharide-conjugated bismuth sulfide nanoparticles through radiosensitization and dendritic cell activation10.1021/acsami.9b07804 ↗
24. Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response10.1016/j.carbpol.2016.01.021 ↗
25. Activation effect of Ganoderma lucidum polysaccharides liposomes on murine peritoneal macrophages10.1016/j.ijbiomac.2015.10.088 ↗
26. Effective cancer immunotherapy by Ganoderma lucidum polysaccharide-gold nanocomposites through dendritic cell activation and memory T cell response10.1016/j.carbpol.2018.10.028 ↗
27. pH and glutathione dual responsive nanoparticles based on Ganoderma lucidum polysaccharide for potential programmable release of three drugs10.1016/j.cej.2020.124418 ↗
28. Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery10.1002/anie.201410223 ↗
29. A novel peptide-equipped exosomes platform for delivery of antisense oligonucleotides10.1021/acsami.1c00016 ↗
30. Self-activatable photo-extracellular vesicle for synergistic trimodal anticancer therapy10.1002/adma.202005562 ↗
31. Role of exosomes in cancer and aptamer-modified exosomes as a promising platform for cancer targeted therapy10.1186/s12575-024-00245-2 ↗
32. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy10.1016/j.jcyt.2019.01.001 ↗
33. Biology and function of exosomes in tumor immunotherapy10.1016/j.biopha.2023.115853 ↗
34. Selenomethionine-conjugated extracellular vesicles for ROS-mediated cell apoptosis10.1021/acsanm.4c01793 ↗
35. Tumor exosomes reprogrammed by low pH are efficient targeting vehicles for smart drug delivery and personalized therapy against their homologous tumor
36. Viral protein-pseudotyped and siRNA-electroporated extracellular vesicles for cancer immunotherapy10.1002/adfm.202006515 ↗
37. Immunomodulatory activities of polysaccharides from Ganoderma on immune effector cells10.1016/j.foodchem.2020.127933 ↗
38. Hollow Calcium/Copper Bimetallic Amplifier for cuproptosis/paraptosis/apoptosis cancer therapy via cascade reinforcement of endoplasmic reticulum stress and mitochondrial dysfunction10.1021/acsnano.4c11455 ↗
39. Tumor microenvironment responsive hollow nanoplatform for triple amplification of oxidative stress to enhance cuproptosis-based synergistic cancer therapy10.1002/adhm.202202949 ↗
40. Development of liposomal Ganoderma lucidum polysaccharide: formulation optimization and evaluation of its immunological activity10.1016/j.carbpol.2014.09.093 ↗
41. The toughness chitosan-PVA double network hydrogel based on alkali solution system and hydrogen bonding for tissue engineering applications10.1016/j.ijbiomac.2019.12.186 ↗
42. A nano drug delivery system based on angelica sinensis polysaccharide for combination of chemotherapy and immunotherapy10.3390/molecules25133096 ↗
43. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery10.1080/10717544.2019.1687614 ↗